Novus Therapeutics begins phase 1 trial of OP0201 in otitis media

Novus Therapeutics has launched a phase 1 pharmacodynamics clinical trial for its promising candidate, OP0201, aimed at treating otitis media—a common middle ear infection. The ... Read More